Ginkgo Bioworks Holdings Inc. (DNA)
NYSE · Healthcare
Ginkgo Bioworks Holdings Inc. Operating Income 2019–2025
Ginkgo Bioworks Holdings Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ginkgo Bioworks Holdings Inc. operating income for the quarter ending March 31, 2026 was -71.4 M, a 11.85% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. operating income for the twelve months ending March 31, 2026 was -307.9 M, a 58.53% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. annual operating income for 2025 was -315.3 M, a 43.68% decrease from 2024.
- Ginkgo Bioworks Holdings Inc. annual operating income for 2024 was -559.8 M, a 35.24% decrease from 2023.
- Ginkgo Bioworks Holdings Inc. annual operating income for 2023 was -864.4 M, a 60.87% decrease from 2022.
- Ginkgo Bioworks Holdings Inc. annual operating income for 2022 was -2.2 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ginkgo Bioworks Holdings Inc. Operating Income — FAQ
Ginkgo Bioworks Holdings Inc. (DNA) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Ginkgo Bioworks Holdings Inc.'s operating income?
Ginkgo Bioworks Holdings Inc. (DNA) reported operating income of -$315M for fiscal 2025.
Where can I see DNA's operating income history?
The chart and table above show Ginkgo Bioworks Holdings Inc.'s operating income by year and by quarter, including the growth rate.